Legal Opinion
Hempstead v. Pfizer, Inc.
District Court, D. South Carolina
Decided December 11, 2015No. MDL No. 2:14-mn-02502-RMGPublishedCited by 3 opinions
1Opinion of the Court
*646CASE MANAGEMENT ORDER NO. 55
Richard Mark Gergel, United States District Court Judge
In this MDL, Plaintiffs allege that Lipitor caused them to develop Type 2 diabetes. To carry their burden, Plaintiffs must prove both general and specific causation. Westberry v. Gislaved Gummi AB, 178 F.3d 257, 263 (4th Cir.1999). The Court will address Plaintiffs’ general causation testimony by separate order. The Court makes no. finding here as to whether the testimony of Plaintiffs’ general causation experts is admissible or whether Plaintiffs can survive summary judgment on the issue of general causation…
2Cases cited21 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Moore v. Ashland Chemical Inc.Court of Appeals for the Fifth Circuit · 1998
- Knight v. Kirby Inland Marine Inc.Court of Appeals for the Fifth Circuit · 2007
- Westberry v. Gislaved Gummi ABCourt of Appeals for the Fourth Circuit · 1999
- Jules R. Viterbo, Et Ux, (Patricia Viterbo) v. The Dow Chemical Co.Court of Appeals for the Fifth Circuit · 1987
16 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
- Jiggetts v. Janseen PharmaceuticalsDistrict Court, D. Maryland · 2019